Novel Cancer Target
Plebiotic SL (Madrid, Spain) and Pharmacellion Ltd (Wirral, UK) have completed a research project on the modelling, structural analysis and molecular dynamics of several Pharmacellion compounds designed to inhibit target protein Na K ATPase, a novel cancer target. The study confirms that all six Pharmacellion compounds studied using the Plebiotic “PleMD” platform bind to their [...]